Post the Weekly IMS txn numbers here

[Anonymous]

The poor little Amarin stock pumper is in panic mode, so he comes to this board to try and make himself feel better with stupid posts like this. Meanwhile, the stock is still a disaster.

I doubt either of you are representatives and this board is intended for reps to discuss company issues.

If you guys want to pump and bash the stock please find the appropriate forum.

 

[Anonymous]

I doubt either of you are representatives and this board is intended for reps to discuss company issues.

If you guys want to pump and bash the stock please find the appropriate forum.

Crappy product and low performing reps, just like this person, results in poor sales.

 

[Anonymous]

Crappy product and low performing reps, just like this person, results in poor sales.

Thankfully, Vascepa is best in class and reps are busting their butts.

 

[Anonymous]

Thankfully, Vascepa is best in class and reps are busting their butts.

What class? EPA only? Yes best, worst and only!

 

[Anonymous]

Where are the numbers? Usually somebody is posting something here on Tuesdays and telling how bad those numbers are. Does that mean the numbers are better?

 

[Anonymous]

Where are the numbers? Usually somebody is posting something here on Tuesdays and telling how bad those numbers are. Does that mean the numbers are better?

The numbers stink. That is why no one is talking about them.

 

[Anonymous]

I'm sooo scared, will someone tell me what to do?
Dumb E

 

[Anonymous]

Nothing but blue skies. Run GSK to your recruiters now.

 

[Anonymous]

The numbers stink. That is why no one is talking about them.

Month of January $140,000 or approximately 735 scripts for the month.

Official launch January 28th

IMS reported weekly's are off, inaccuracies secondary to tracking mechanism. Vascepa's early scrips will be based on 1000 high prescribers not captured by IMS's weekly's.

February's scripts could finish as high as 10,000.

 

[Anonymous]

Month of January $140,000 or approximately 735 scripts for the month.

Official launch January 28th

IMS reported weekly's are off, inaccuracies secondary to tracking mechanism. Vascepa's early scrips will be based on 1000 high prescribers not captured by IMS's weekly's.

February's scripts could finish as high as 10,000.

Another brain dead post by a stock pumper. All prescribers are covered by IMS. What is missing is that certain retail stores do not submit prescription data to IMS. IMS covers this gap by projecting prescriptions based on data from surrounding pharmacies. They already now what flows into the pharmacies based on DDD data and then uses the samples from surrounding pharmacies to allocate (project) the missing data.

 

[Anonymous]

Another brain dead post by a stock pumper. All prescribers are covered by IMS. What is missing is that certain retail stores do not submit prescription data to IMS. IMS covers this gap by projecting prescriptions based on data from surrounding pharmacies. They already now what flows into the pharmacies based on DDD data and then uses the samples from surrounding pharmacies to allocate (project) the missing data.

Projecting data currently is not accurate for the weekly's. January monthly sales $140 k, 735 scripts

Add week estimates do they equal the accurate monthly number? No

"Projection" currently not accurate.

 

[Anonymous]

Projecting data currently is not accurate for the weekly's. January monthly sales $140 k, 735 scripts

Add week estimates do they equal the accurate monthly number? No

"Projection" currently not accurate.

So now that you figured out you were wrong, you want to come back and try and spin things around yet again. Do you also know that the sales are gross and not net. The $140K is not even close to the actual number. Just a clue: it is a lot lower.

 

[Anonymous]

Sales are off to a bad start. That is why the stock price dropped.

 

[Anonymous]

So, maybe we hand out cans of sardines?
Krill oil lube jobs?
fish oil salad dressing?
Doo bee

 

[Anonymous]

Sales are off to a bad start. That is why the stock price dropped.

Duh, and I thought it was because the whole market has been down. Nice try dumb ass GSK.Abbvie reps. To the bread line with you.

 

[Anonymous]

Duh, and I thought it was because the whole market has been down. Nice try dumb ass GSK.Abbvie reps. To the bread line with you.

You are not that bright, are you.

 

[Anonymous]

I called on a doc who wrote a script of VASCEPA for me... I was on an respiratory product call...Are docs being paid to write it?

 

[Anonymous]

I called on a doc who wrote a script of VASCEPA for me... I was on an respiratory product call...Are docs being paid to write it?

B.S. post.

 

[Anonymous]

You're right, I'm not that smart - last in class

 

[Anonymous]

B.S. post.

no, really.